Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InterCure Ltd. stock logo
INCR
InterCure
$1.45
-2.3%
$1.48
$1.17
$2.62
$65.90M1.2226,876 shs4,378 shs
JATT Acquisition Corp stock logo
JATT
JATT Acquisition
$1.20
-1.6%
$1.21
$7.80
$12.38
$20.70MN/A41,322 shs246,312 shs
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$0.34
-4.3%
$0.34
$0.30
$0.80
$64.29M0.8910,845 shs2,477 shs
Surrozen, Inc. stock logo
SRZN
Surrozen
$9.48
+0.9%
$8.93
$5.90
$18.17
$81.15M0.5721,141 shs16,583 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InterCure Ltd. stock logo
INCR
InterCure
0.00%-3.60%-4.24%-10.74%-40.74%
JATT Acquisition Corp stock logo
JATT
JATT Acquisition
-1.64%-4.76%+2.56%-6.25%-68.67%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.00%-6.69%+0.61%-14.03%-24.80%
Surrozen, Inc. stock logo
SRZN
Surrozen
0.00%+11.53%+38.39%-18.21%-17.06%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
InterCure Ltd. stock logo
INCR
InterCure
0.3807 of 5 stars
0.03.00.00.01.90.00.6
JATT Acquisition Corp stock logo
JATT
JATT Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.1643 of 5 stars
0.02.00.00.00.91.70.0
Surrozen, Inc. stock logo
SRZN
Surrozen
3.799 of 5 stars
3.53.00.00.03.85.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InterCure Ltd. stock logo
INCR
InterCure
0.00
N/AN/AN/A
JATT Acquisition Corp stock logo
JATT
JATT Acquisition
0.00
N/AN/AN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.00
N/AN/AN/A
Surrozen, Inc. stock logo
SRZN
Surrozen
3.00
Buy$38.50306.12% Upside

Current Analyst Ratings Breakdown

Latest JATT, PYRGF, INCR, and SRZN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2025
Surrozen, Inc. stock logo
SRZN
Surrozen
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$32.00 ➝ $32.00
4/2/2025
Surrozen, Inc. stock logo
SRZN
Surrozen
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$32.00 ➝ $32.00
(Data available from 6/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InterCure Ltd. stock logo
INCR
InterCure
$238.85M0.28N/AN/A$2.72 per share0.53
JATT Acquisition Corp stock logo
JATT
JATT Acquisition
N/AN/A$0.04 per share27.08($0.53) per shareN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$9.14M7.03N/AN/A($0.01) per share-34.44
Surrozen, Inc. stock logo
SRZN
Surrozen
$11.64M6.98N/AN/A$18.39 per share0.52
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InterCure Ltd. stock logo
INCR
InterCure
-$16.83MN/A0.00N/AN/AN/AN/AN/A
JATT Acquisition Corp stock logo
JATT
JATT Acquisition
$6.85MN/A0.00N/AN/A-49.58%2.84%N/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
-$21.12M-$0.02N/AN/A-115.14%N/A-60.81%N/A
Surrozen, Inc. stock logo
SRZN
Surrozen
-$43.04M-$24.96N/AN/AN/AN/A-120.51%-54.68%8/11/2025 (Estimated)

Latest JATT, PYRGF, INCR, and SRZN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2025Q1 2025
Surrozen, Inc. stock logo
SRZN
Surrozen
-$1.09-$3.13-$2.04-$7.43N/A$0.98 million
3/31/2025Q4 2024
Surrozen, Inc. stock logo
SRZN
Surrozen
-$2.54-$9.10-$6.56-$9.10N/A$0.66 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
InterCure Ltd. stock logo
INCR
InterCure
N/AN/AN/AN/AN/A
JATT Acquisition Corp stock logo
JATT
JATT Acquisition
N/AN/AN/AN/AN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
N/AN/AN/AN/AN/A
Surrozen, Inc. stock logo
SRZN
Surrozen
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InterCure Ltd. stock logo
INCR
InterCure
0.15
1.78
1.15
JATT Acquisition Corp stock logo
JATT
JATT Acquisition
N/A
0.15
0.15
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
N/A
0.60
0.50
Surrozen, Inc. stock logo
SRZN
Surrozen
N/A
7.40
7.40

Institutional Ownership

CompanyInstitutional Ownership
InterCure Ltd. stock logo
INCR
InterCure
8.34%
JATT Acquisition Corp stock logo
JATT
JATT Acquisition
47.97%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.03%
Surrozen, Inc. stock logo
SRZN
Surrozen
66.57%

Insider Ownership

CompanyInsider Ownership
InterCure Ltd. stock logo
INCR
InterCure
0.24%
JATT Acquisition Corp stock logo
JATT
JATT Acquisition
20.00%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
47.68%
Surrozen, Inc. stock logo
SRZN
Surrozen
45.18%
CompanyEmployeesShares OutstandingFree FloatOptionable
InterCure Ltd. stock logo
INCR
InterCure
35045.57 million45.46 millionOptionable
JATT Acquisition Corp stock logo
JATT
JATT Acquisition
317.25 million13.80 millionNot Optionable
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
90186.69 million96.34 millionNo Data
Surrozen, Inc. stock logo
SRZN
Surrozen
808.56 million1.84 millionNot Optionable

Recent News About These Companies

Surrozen files to sell 5.21M shares of common stock for holders
Surrozen reports FY24 EPS ($21.67) vs. ($21.33) last year
(SRZN) Trading Advice
Surrozen initiated with a Buy at H.C. Wainwright

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
InterCure stock logo

InterCure NASDAQ:INCR

$1.45 -0.03 (-2.30%)
Closing price 06/13/2025 03:57 PM Eastern
Extended Trading
$1.44 0.00 (-0.07%)
As of 06/13/2025 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

JATT Acquisition stock logo

JATT Acquisition NYSE:JATT

$1.20 -0.02 (-1.64%)
As of 06/13/2025

JATT Acquisition Corp does not have significant operations. It intends to effect a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company intends to focus on businesses primarily operating in the life sciences sector. JATT Acquisition Corp was incorporated in 2021 and is based in Grand Cayman, the Cayman Islands.

PyroGenesis Canada stock logo

PyroGenesis Canada NASDAQ:PYRGF

$0.34 -0.02 (-4.33%)
As of 06/13/2025 03:59 PM Eastern

PyroGenesis Canada Inc. designs, develops, manufactures, and commercializes plasma processes and solutions worldwide. The company offers DROSRITE, a process for enhancing metal recovery from dross without any hazardous by-products; plasma atomization process that allows produce and sell high purity spherical metal powders; PUREVAP, a process to produce high purity metallurgical and solar grade silicon from quartz; and PUREVAP NSiR, which is designed to transform silicon into spherical silicon nano powders and nanowires for use in lithium-ion batteries. It provides plasma torches and plasma torch systems used toreplace fossil fuel burners in industrial iron ore pelletization process; plasma arc waste destruction systems for waste destruction onboard ships; steam plasma arc refrigerant cracking systems for the destruction of certain refrigerants, including chlorofluorocarbons, hydrofluorocarbons, and hydrochlorofluorocarbons; plasma arc chemical warfare agent destruction systems, which are mobile platforms for the onsite destruction of chemical warfare agents; plasma resource recovery systems for land-based waste destruction and waste-to-energy applications; plasma torches for waste gasification and combustion; and plasma arc gasification and vitrification. In addition, it offers engineering and manufacturing expertise, and contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (including 3D printing), oil and gas, and environmental industries. Further, the company provides installation, commissioning, and start-up services. PyroGenesis Canada Inc. is headquartered in Montreal, Canada.

Surrozen stock logo

Surrozen NASDAQ:SRZN

$9.48 +0.08 (+0.85%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$9.42 -0.06 (-0.63%)
As of 06/13/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcohol-associated hepatitis. The company develops SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. is based in South San Francisco, California.